Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

First application of 7-T ultra-high field diffusion tensor imaging to detect altered microstructure of thalamic-somatosensory anatomy in trigeminal neuralgia.

Rutland JW, Huang KH, Gill CM, Villavisanis DF, Alper J, Verma G, Bederson JB, Delman BN, Shrivastava RK, Balchandani P.

J Neurosurg. 2019 Aug 30:1-9. doi: 10.3171/2019.6.JNS19541. [Epub ahead of print]

PMID:
31470412
2.

Structural MRI at 7T reveals amygdala nuclei and hippocampal subfield volumetric association with Major Depressive Disorder symptom severity.

Brown SSG, Rutland JW, Verma G, Feldman RE, Alper J, Schneider M, Delman BN, Murrough JM, Balchandani P.

Sci Rep. 2019 Jul 15;9(1):10166. doi: 10.1038/s41598-019-46687-7.

3.

Resistance is futile: Centering forces yield for asymmetric cell division.

Alper J, Zanic M.

J Cell Biol. 2019 Mar 4;218(3):727-728. doi: 10.1083/jcb.201902039. Epub 2019 Feb 15.

4.

From isolated structures to continuous networks: A categorization of cytoskeleton-based motile engineered biological microstructures.

Andorfer R, Alper JD.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2019 Jul;11(4):e1553. doi: 10.1002/wnan.1553. Epub 2019 Feb 11. Review.

PMID:
30740918
5.

E-hooks provide guidance and a soft landing for the microtubule binding domain of dynein.

Tajielyato N, Li L, Peng Y, Alper J, Alexov E.

Sci Rep. 2018 Sep 5;8(1):13266. doi: 10.1038/s41598-018-31480-9.

6.

Forces and Disease: Electrostatic force differences caused by mutations in kinesin motor domains can distinguish between disease-causing and non-disease-causing mutations.

Li L, Jia Z, Peng Y, Godar S, Getov I, Teng S, Alper J, Alexov E.

Sci Rep. 2017 Aug 15;7(1):8237. doi: 10.1038/s41598-017-08419-7.

7.

Is There a Magnetic Resonance Imaging-Discernible Cause for Trigeminal Neuralgia? A Structured Review.

Alper J, Shrivastava RK, Balchandani P.

World Neurosurg. 2017 Feb;98:89-97. doi: 10.1016/j.wneu.2016.10.104. Epub 2016 Oct 27. Review.

8.

Mechanism of microtubule lumen entry for the α-tubulin acetyltransferase enzyme αTAT1.

Coombes C, Yamamoto A, McClellan M, Reid TA, Plooster M, Luxton GW, Alper J, Howard J, Gardner MK.

Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):E7176-E7184. Epub 2016 Nov 1.

9.

Cytoplasmic dynein binding, run length, and velocity are guided by long-range electrostatic interactions.

Li L, Alper J, Alexov E.

Sci Rep. 2016 Aug 17;6:31523. doi: 10.1038/srep31523.

10.
11.

High-Temperature All Solid-State Microsupercapacitors based on SiC Nanowire Electrode and YSZ Electrolyte.

Chang CH, Hsia B, Alper JP, Wang S, Luna LE, Carraro C, Lu SY, Maboudian R.

ACS Appl Mater Interfaces. 2015 Dec 9;7(48):26658-65. doi: 10.1021/acsami.5b08423. Epub 2015 Nov 20.

PMID:
26569457
12.

Apremilast in Patients With Active Rheumatoid Arthritis: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study.

Genovese MC, Jarosova K, Cieślak D, Alper J, Kivitz A, Hough DR, Maes P, Pineda L, Chen M, Zaidi F.

Arthritis Rheumatol. 2015 Jul;67(7):1703-10. doi: 10.1002/art.39120.

13.

The motility of axonemal dynein is regulated by the tubulin code.

Alper JD, Decker F, Agana B, Howard J.

Biophys J. 2014 Dec 16;107(12):2872-2880. doi: 10.1016/j.bpj.2014.10.061.

14.

The attitudes of social work students toward end-of-life care planning.

Kwon SA, Kolomer S, Alper J.

J Soc Work End Life Palliat Care. 2014;10(3):240-56. doi: 10.1080/15524256.2014.938890.

PMID:
25148452
15.

Selective ultrathin carbon sheath on porous silicon nanowires: materials for extremely high energy density planar micro-supercapacitors.

Alper JP, Wang S, Rossi F, Salviati G, Yiu N, Carraro C, Maboudian R.

Nano Lett. 2014;14(4):1843-7. doi: 10.1021/nl404609a. Epub 2014 Mar 27.

PMID:
24635718
16.
17.

Semiconductor nanowires directly grown on graphene--towards wafer scale transferable nanowire arrays with improved electrical contact.

Alper JP, Gutes A, Carraro C, Maboudian R.

Nanoscale. 2013 May 21;5(10):4114-8. doi: 10.1039/c3nr00367a.

PMID:
23563903
18.

Reconstitution of flagellar sliding.

Alper J, Geyer V, Mukundan V, Howard J.

Methods Enzymol. 2013;524:343-69. doi: 10.1016/B978-0-12-397945-2.00019-6.

PMID:
23498749
19.

One-step purification of assembly-competent tubulin from diverse eukaryotic sources.

Widlund PO, Podolski M, Reber S, Alper J, Storch M, Hyman AA, Howard J, Drechsel DN.

Mol Biol Cell. 2012 Nov;23(22):4393-401. doi: 10.1091/mbc.E12-06-0444. Epub 2012 Sep 19.

20.

Investigation of quaternary ammonium silane-coated sand filter for the removal of bacteria and viruses from drinking water.

Torkelson AA, da Silva AK, Love DC, Kim JY, Alper JP, Coox B, Dahm J, Kozodoy P, Maboudian R, Nelson KL.

J Appl Microbiol. 2012 Nov;113(5):1196-207. doi: 10.1111/j.1365-2672.2012.05411.x. Epub 2012 Aug 30.

21.

Management of proximal femoral fractures 2011: Association of Anaesthetists of Great Britain and Ireland.

Association of Anaesthetists of Great Britain and Ireland, Griffiths R, Alper J, Beckingsale A, Goldhill D, Heyburn G, Holloway J, Leaper E, Parker M, Ridgway S, White S, Wiese M, Wilson I.

Anaesthesia. 2012 Jan;67(1):85-98. doi: 10.1111/j.1365-2044.2011.06957.x.

22.

Hybrid four-headed myosin motor engineered with antagonistic motor domains.

Alper J, Howard J.

Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):15663-4. doi: 10.1073/pnas.1112017108. Epub 2011 Sep 7. No abstract available.

23.

International approaches to advancing biospecimen science.

Moore HM, Compton CC, Alper J, Vaught JB.

Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):729-32. doi: 10.1158/1055-9965.EPI-11-0021. Epub 2011 Mar 23.

24.

Newsmaker: Agios Pharmaceuticals.

Alper J, Melton L.

Nat Biotechnol. 2010 Jul;28(7):639. doi: 10.1038/nbt0710-639. No abstract available.

PMID:
20622823
25.

Strategic workshops on cancer nanotechnology.

Nagahara LA, Lee JS, Molnar LK, Panaro NJ, Farrell D, Ptak K, Alper J, Grodzinski P.

Cancer Res. 2010 Jun 1;70(11):4265-8. doi: 10.1158/0008-5472.CAN-09-3716. Epub 2010 May 11.

26.

Recent advances from the National Cancer Institute Alliance for Nanotechnology in Cancer.

Farrell D, Alper J, Ptak K, Panaro NJ, Grodzinski P, Barker AD.

ACS Nano. 2010 Feb 23;4(2):589-94. doi: 10.1021/nn100073g.

PMID:
20175564
27.

Effect of ligands on thermal dissipation from gold nanorods.

Alper J, Hamad-Schifferli K.

Langmuir. 2010 Mar 16;26(6):3786-9. doi: 10.1021/la904855s.

PMID:
20166728
28.

Biotech in the basement.

Alper J.

Nat Biotechnol. 2009 Dec;27(12):1077-8. doi: 10.1038/nbt1209-1077. No abstract available.

PMID:
20010575
29.

2009 Biospecimen research network symposium: advancing cancer research through biospecimen science.

Moore HM, Compton CC, Lim MD, Vaught J, Christiansen KN, Alper J.

Cancer Res. 2009 Sep 1;69(17):6770-2. doi: 10.1158/0008-5472.CAN-09-1795. Epub 2009 Aug 25.

30.

One-off therapy for HIV.

Alper J.

Nat Biotechnol. 2009 Apr;27(4):300. doi: 10.1038/nbt0409-300. No abstract available.

PMID:
19352349
31.

Geron gets green light for human trial of ES cell-derived product.

Alper J.

Nat Biotechnol. 2009 Mar;27(3):213-4. doi: 10.1038/nbt0309-213a. No abstract available.

PMID:
19270655
32.

Microsized "giant" drives new rapid-screening device.

Alper J.

Anal Chem. 2008 Nov 1;80(21):7905. doi: 10.1021/ac801967k. Epub 2008 Oct 10. No abstract available.

PMID:
18844372
33.

New wrinkle in digital microfluidics.

Alper J.

Anal Chem. 2008 Jul 1;80(13):4788. No abstract available.

PMID:
18609762
34.

Profile: Fred Kavli.

Alper J.

Nat Biotechnol. 2008 Jun;26(6):600. doi: 10.1038/nbt0608-600. No abstract available.

PMID:
18536671
35.

Stamping out SERS substrates.

Alper J.

Anal Chem. 2008 Apr 1;80(7):2304. No abstract available.

PMID:
18456911
36.
37.

Both sides now...

Campbell N, Utting MR, Alper J.

Anaesthesia. 2006 Dec;61(12):1231. No abstract available.

38.

Massively parallel single-cell analyses.

Alper J.

Anal Chem. 2006 Aug 1;78(15):5249-50. No abstract available.

PMID:
16913056
39.

Building microfluidic devices one drop at a time.

Alper J.

Anal Chem. 2006 Jun 1;78(11):3508. No abstract available.

PMID:
16802463
40.

Hitting the magic angle for cell wall analysis.

Alper J.

Anal Chem. 2005 Oct 1;77(19):371A. No abstract available.

PMID:
16247928
41.

US NCI launches nanotechnology plan.

Alper J.

Nat Biotechnol. 2004 Nov;22(11):1335-6. No abstract available.

PMID:
15529140
42.

Bioengineering. Biology and the inkjets.

Alper J.

Science. 2004 Sep 24;305(5692):1895. No abstract available.

PMID:
15448239
43.

High-throughput proteomics for alcohol research.

Neuhold LA, Guo QM, Alper J, Velazquez JM.

Alcohol Clin Exp Res. 2004 Feb;28(2):203-10.

PMID:
15112927
44.

California's biogoddess.

Alper J.

Nat Biotechnol. 2003 Jul;21 Suppl:BE13-4. No abstract available.

PMID:
12874971
45.

The money men.

Alper J.

Nat Biotechnol. 2003 Jul;21 Suppl:BE7-12. No abstract available.

PMID:
12874970
46.

Glycobiology. Turning sweet on cancer.

Alper J.

Science. 2003 Jul 11;301(5630):159-60. No abstract available.

PMID:
12855785
47.

Biotechnology. Hatching the golden egg: a new way to make drugs.

Alper J.

Science. 2003 May 2;300(5620):729-30. No abstract available.

PMID:
12730574
48.

Water splitting goes au naturel.

Alper J.

Science. 2003 Mar 14;299(5613):1686-7. No abstract available.

PMID:
12637732
49.

Drug development. Biotech thinking comes to academic medical centers.

Alper J.

Science. 2003 Feb 28;299(5611):1303-5. No abstract available.

PMID:
12610271
50.

Racism: a central problem for the Human Genome Diversity Project.

Alper JS, Beckwith J.

Politics Life Sci. 1999 Sep;18(2):285-8. No abstract available.

PMID:
12542056

Supplemental Content

Support Center